Sex: U
Vaccine: DTAP, DTAPHEPBIP, DTAPIPV, HEP, HEPA, HIBV, MENB, MNQ, TDAP, VARZOS
Symptoms: Product storage error
Clinical narrative: Potential administration of Bexsero, Menveo, Havrix, Kinrix, Pediarix, Shingrix, Boostrix, Infanrix, Engerix-B, Hiberix stored at -0.93C for an unknown amount of time; This case was reported by a nurse via call center representative and described the occurrence of incorrect storage of drug in an unspecified number of patients who received Men B NVS (Bexsero) for prophylaxis.   Co-suspect products included meningococcal B recom vaccine + aloh + omv pre-filled syringe device (Bexsero Pre-Filled Syringe Device) injection syringe for prophylaxis, Men ACWY-CRM NVS (Menveo) for prophylaxis, HAV (Havrix) for prophylaxis, DTPa-IPV (Kinrix) for prophylaxis, dtpa-ipv vaccine pre-filled syringe device (Kinrix Pre-Filled Syringe Device) injection syringe for prophylaxis, DTPa-HBV-IPV (Pediarix) for prophylaxis, dtpa-hbv-ipv vaccine pre-filled syringe device (Pediarix Pre-Filled Syringe Device) injection syringe for prophylaxis, Herpes zoster (Shingrix) for prophylaxis, DTPa (Reduced antigen) (Boostrix) for prophylaxis, DTPa (Infanrix) for prophylaxis, dtpa vaccine pre-filled syringe device (Infanrix Pre-Filled Syringe Device) injection syringe for prophylaxis, HBV (Engerix B) for prophylaxis and Hib (Hiberix) for prophylaxis.   On an unknown date, the patient received Bexsero, Bexsero Pre-Filled Syringe Device, Menveo, Havrix, Kinrix, Kinrix Pre-Filled Syringe Device, Pediarix, Pediarix Pre-Filled Syringe Device, Shingrix, Boostrix, Infanrix, Infanrix Pre-Filled Syringe Device, Engerix B and Hiberix. On an unknown date, unknown after receiving Bexsero, Bexsero Pre-Filled Syringe Device, Menveo, Havrix, Kinrix, Kinrix Pre-Filled Syringe Device, Pediarix, Pediarix Pre-Filled Syringe Device, Shingrix, Boostrix, Infanrix, Infanrix Pre-Filled Syringe Device, Engerix B and Hiberix, the patient experienced incorrect storage of drug. On an unknown date, the outcome of the incorrect storage of drug was unknown.     This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK Receipt Date: 15-JUL-2022 Reporter's comment: Registered nurse reported potential administration of Bexsero, Menveo, Havrix, Kinrix, Pediarix, Shingrix, Boostrix, Infanrix, Engerix-B, Hiberix stored at minus 0.93 degree Celsius for an unknown amount of time. Prior excursion on 27 March 2022 for minus 0.84 degree Celsius unknown time. Healthcare professional stated that 587 doses of vaccines had been administered from 27 March 2022 up until 13 July 2022 to 363 individual patients. It was unknown which vaccines had been administered. The consent to follow up was given. The reporter stated that once reports are available GSK would update with specific lot numbers and vaccines that was administered to patients. No additional details were available at this time. Additional supportive information: Registered nurse reported potential administration of Bexsero, Menveo, Havrix, Kinrix, Pediarix, Shingrix, Boostrix, Infanrix, Engerix-B, Hiberix stored at minus 0.93 degree Celsius for an unknown amount of time which led to incorrect storage of vaccine.